The announcement of a public offering often leads to a decrease in the company's stock price. This is because existing shares are diluted, and investors may sell their shares anticipating this dilution. In this case, Galmed Pharmaceuticals has announced a $7 million public offering, which is likely to lead to a decrease in its stock price in the short term.